129 related articles for article (PubMed ID: 22792778)
21. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
22. Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts.
Vaes BL; Dechering KJ; van Someren EP; Hendriks JM; van de Ven CJ; Feijen A; Mummery CL; Reinders MJ; Olijve W; van Zoelen EJ; Steegenga WT
Bone; 2005 May; 36(5):803-11. PubMed ID: 15820155
[TBL] [Abstract][Full Text] [Related]
23. Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts.
Chan TF; Couchourel D; Abed E; Delalandre A; Duval N; Lajeunesse D
J Bone Miner Res; 2011 Jul; 26(7):1399-410. PubMed ID: 21312269
[TBL] [Abstract][Full Text] [Related]
24. miR‑142‑3p promotes osteoblast differentiation by modulating Wnt signaling.
Hu W; Ye Y; Zhang W; Wang J; Chen A; Guo F
Mol Med Rep; 2013 Feb; 7(2):689-93. PubMed ID: 23229013
[TBL] [Abstract][Full Text] [Related]
25. Small molecule T63 suppresses osteoporosis by modulating osteoblast differentiation via BMP and WNT signaling pathways.
Zhao XL; Chen JJ; Zhang GN; Wang YC; Si SY; Chen LF; Wang Z
Sci Rep; 2017 Sep; 7(1):10397. PubMed ID: 28871136
[TBL] [Abstract][Full Text] [Related]
26. Regulation of osteoblastic differentiation by the proteasome inhibitor bortezomib.
Uyama M; Sato MM; Kawanami M; Tamura M
Genes Cells; 2012 Jul; 17(7):548-58. PubMed ID: 22702336
[TBL] [Abstract][Full Text] [Related]
27. Dietary-induced serum phenolic acids promote bone growth via p38 MAPK/β-catenin canonical Wnt signaling.
Chen JR; Lazarenko OP; Wu X; Kang J; Blackburn ML; Shankar K; Badger TM; Ronis MJ
J Bone Miner Res; 2010 Nov; 25(11):2399-411. PubMed ID: 20499363
[TBL] [Abstract][Full Text] [Related]
28. Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge.
Anastasilakis AD; Polyzos SA; Toulis KA
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):383-8. PubMed ID: 21897222
[TBL] [Abstract][Full Text] [Related]
29. The epithelial sodium channel is involved in dexamethasone-induced osteoblast differentiation and mineralization.
Lu L; Wu L; Jia H; Li Y; Chen J; Xu D; Li Q
Cell Biol Toxicol; 2012 Oct; 28(5):279-89. PubMed ID: 22752439
[TBL] [Abstract][Full Text] [Related]
30. Mechanical stress induces Interleukin-11 expression to stimulate osteoblast differentiation.
Kido S; Kuriwaka-Kido R; Imamura T; Ito Y; Inoue D; Matsumoto T
Bone; 2009 Dec; 45(6):1125-32. PubMed ID: 19665600
[TBL] [Abstract][Full Text] [Related]
31. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
32. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
[TBL] [Abstract][Full Text] [Related]
33. The emerging role of microRNAs in bone remodeling and its therapeutic implications for osteoporosis.
Feng Q; Zheng S; Zheng J
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29848766
[TBL] [Abstract][Full Text] [Related]
34. miR300 intervenes Smad3/β-catenin/RunX2 crosstalk for therapy with an alternate function as indicative biomarker in osteoporosis.
Kaur T; John AA; Sharma C; Vashisht NK; Singh D; Kapila R; Kapila S
Bone; 2021 Feb; 143():115603. PubMed ID: 32827850
[TBL] [Abstract][Full Text] [Related]
35. PDZRN3 negatively regulates BMP-2-induced osteoblast differentiation through inhibition of Wnt signaling.
Honda T; Yamamoto H; Ishii A; Inui M
Mol Biol Cell; 2010 Sep; 21(18):3269-77. PubMed ID: 20668165
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of palmitate-induced lipotoxicity in human osteoblasts.
Gunaratnam K; Vidal C; Gimble JM; Duque G
Endocrinology; 2014 Jan; 155(1):108-16. PubMed ID: 24169557
[TBL] [Abstract][Full Text] [Related]
37. Interplay between microRNAs and Wnt, transforming growth factor-β, and bone morphogenic protein signaling pathways promote osteoblastic differentiation of mesenchymal stem cells.
Aslani S; Abhari A; Sakhinia E; Sanajou D; Rajabi H; Rahimzadeh S
J Cell Physiol; 2019 Jun; 234(6):8082-8093. PubMed ID: 30548580
[TBL] [Abstract][Full Text] [Related]
38. [The expression and significance of Wnt/beta-catenin signal pathway protein in the effect of bushen huoxue granule containing serum on the osteoblast].
Xu YX; Wu CL; Wu Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):537-41. PubMed ID: 21608229
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol prevents osteoporosis in ovariectomized rats by regulating microRNA-338-3p.
Guo DW; Han YX; Cong L; Liang D; Tu GJ
Mol Med Rep; 2015 Aug; 12(2):2098-106. PubMed ID: 25845653
[TBL] [Abstract][Full Text] [Related]
40. Regulation of Runx2 by MicroRNAs in osteoblast differentiation.
Narayanan A; Srinaath N; Rohini M; Selvamurugan N
Life Sci; 2019 Sep; 232():116676. PubMed ID: 31340165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
